Actovegin 200 mg 50 tablets | Tissue Metabolism Booster | Enhances Brain Oxygenation & Glucose Uptake

Actovegin 200 mg is a film-coated tablet formulation containing a deproteinized hemoderivative of calf blood as its active substance. It belongs to the pharmacotherapeutic group of **tissue regeneration stimulators** and is used as part of combination therapy for cognitive, peripheral circulatory, and diabetic neuropathic conditions. If you are looking to **buy Actovegin 200mg pills USA**, this summary covers the essential prescribing information you should review first.

📋 Indications

Used as part of combination therapy:
* **Symptomatic treatment of cognitive disorders**, including post-stroke cognitive impairment and dementia.
* **Symptomatic treatment of peripheral circulatory disorders** and their consequences.
* **Symptomatic treatment of diabetic polyneuropathy (DPN).**

💊 Composition

1 film-coated tablet contains:
* **Core**: Active substance: blood components: deproteinized hemoderivative of calf blood – 200.0 mg (in the form of Actovegin granulate* – 345.0 mg). Excipients: magnesium stearate – 2.0 mg, talc – 3.0 mg.
* **Coating**: acacia gum – 6.8 mg, glyceryl montanate wax – 0.1 mg, hypromellose phthalate – 29.45 mg, diethyl phthalate – 11.8 mg, quinoline yellow aluminum lake dye – 2.0 mg, macrogol-6000 – 2.95 mg, povidone-K30 – 1.54 mg, sucrose – 52.3 mg, talc – 42.2 mg, titanium dioxide – 0.86 mg.

*Actovegin granulate contains: active substance: blood components: deproteinized hemoderivative of calf blood – 200.0 mg; excipients: povidone-K90 – 10.0 mg, microcrystalline cellulose – 135.0 mg.

💧 Dosage and Administration

Administered **orally**, without chewing, **before meals**, with a small amount of liquid.

* **Post-stroke cognitive impairment**: In the acute period of ischemic stroke, starting from day 5–7, **2000 mg per day intravenously by drip** for up to 20 infusions, followed by a switch to the tablet form at **2 tablets 3 times daily (1200 mg/day)**. Total duration of treatment: **6 months**.
* **Dementia**: **2 tablets 3 times daily (1200 mg/day)**. Total duration of treatment: **20 weeks**.
* **Peripheral circulatory disorders and their consequences**: **1–2 tablets 3 times daily (600–1200 mg/day)**. Duration of treatment: **4 to 6 weeks**.
* **Diabetic polyneuropathy**: **2000 mg per day intravenously by drip** for 20 infusions, followed by a switch to the tablet form at **3 tablets 3 times daily (1800 mg/day)**; duration: **4 to 5 months**.

Patients who decide to **buy Actovegin 200mg pills USA** should follow the prescribed regimen strictly, since the dosing differs significantly between indications.

⚠️ Contraindications

* Hypersensitivity to Actovegin® and similar drugs or to any excipients.
* Fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase deficiency.
* Children and adolescents **under 18 years of age**.

**With caution**: Pregnancy and breastfeeding.

🤰 Use in Pregnancy and Breastfeeding

Actovegin should be used only when the therapeutic benefit outweighs the potential risk to the fetus or infant.

📌 Special Precautions

**Clinical data**: In the multicenter, randomized, double-blind, placebo-controlled ARTEMIDA study (NCT01582854), which aimed to evaluate the therapeutic effect of Actovegin® on cognitive impairment in 503 patients with ischemic stroke, the overall incidence of serious adverse events and death was the same in both treatment groups. Although the rate of recurrent ischemic strokes was within the range expected in this patient population, a higher number of cases was recorded in the Actovegin® group compared with the placebo group; however, this difference was statistically non-significant. No causal relationship between recurrent stroke cases and the study drug was established.

**Use in pediatric patients**: Currently, there are no data on the use of Actovegin in children; therefore, its use in this population is not recommended.

**Effect on ability to drive and operate machinery**: Not established.

📦 Packaging and Dosage Form

Film-coated tablets, 200 mg – 50 tablets per pack.

**Description**: Round, biconvex, film-coated tablets of a greenish-yellow color, glossy.

⚡ Side Effects

The frequency of adverse effects was determined according to the Council for International Organizations of Medical Sciences (CIOMS) classification: very common (> 1/10); common (> 1/100 to < 1/10); uncommon (> 1/1000 to < 1/100); rare (> 1/10000 to < 1/1000); very rare (< 1/10000); unknown (cannot be estimated from available data).

* **Immune system disorders** – Rare: allergic reactions (drug fever, shock symptoms).
* **Skin and subcutaneous tissue disorders** – Rare: urticaria, sudden flushing.

 🔄 Interaction with Other Medicinal Products

Currently unknown.

🧬 Pharmacodynamics

Actovegin® is an **antihypoxant** that produces three types of effects: metabolic, neuroprotective, and microcirculatory.

Actovegin increases oxygen uptake and utilization; the inositol phospho-oligosaccharides contained in the drug positively influence glucose transport and utilization, which leads to improved cellular energy metabolism and reduced lactate formation under ischemic conditions.

Several pathways are considered for the neuroprotective mechanism of action. Actovegin prevents apoptosis induced by beta-amyloid peptide (Aβ(25–35)). Actovegin modulates the activity of nuclear factor kappa B (NF-κB), which plays an important role in regulating apoptosis and inflammation in the central and peripheral nervous system. Another mechanism is associated with the nuclear enzyme poly(ADP-ribose) polymerase (PARP). PARP plays an important role in detecting and repairing single-strand DNA damage; however, excessive activation of the enzyme can trigger cell death processes in conditions such as cerebrovascular diseases and diabetic polyneuropathy. Actovegin inhibits PARP activity, resulting in functional and morphological improvement of the central and peripheral nervous system.

The positive effects of Actovegin on microcirculation and the endothelium include increased capillary blood flow velocity, reduced pericapillary zone, decreased myogenic tone of precapillary arterioles and capillary sphincters, reduced arteriovenous shunting with predominant capillary blood flow, and stimulation of endothelial nitric oxide synthase function affecting the microvascular bed.

Various studies have established that the effect of Actovegin occurs no later than 30 minutes after administration. The maximum effect is observed 3 hours after parenteral administration and 2–6 hours after oral administration. Those who **buy Actovegin 200mg pills USA** for oral use should expect the peak effect within this 2–6 hour window.

🌡️ Storage Temperature

From 2 °C to 25 °C.

🧪 Pharmacokinetics

Pharmacokinetic parameters of Actovegin cannot be studied using pharmacokinetic methods, since it consists solely of physiological components normally present in the body.

🚨 Overdose

According to preclinical studies, Actovegin does not exhibit toxic effects even when the dose is exceeded 30–40 times compared with doses recommended for human use. No cases of Actovegin overdose have been reported.